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Introduction
Glycosaminoglycans (GAGs) are the most abundant het-
eropolysaccharides in the human eye. These molecules are long, 
unbranched polysaccharides containing a repeating disaccha-
ride unit. The disaccharide units contain one of two modi-
fied sugars (N-acetylgalactosamine or N-acetylglucosamine) 
and a uronic acid, such as glucuronate or iduronate. GAGs are 
highly negatively charged molecules, with an extended con-
formation that imparts high viscosity to solutions.
Their biophysical functions depend on their unique 
proper ties: the ability to fill a space, to bind and organize 
water molecules, and to repel negatively charged molecules. 
Because of high viscosity and low compressibility, they are 
ideal lubricants in the eyes. On the other hand, their rigidity 
provides cells with structural integrity and resistance to 
deformation, and allows cell migration.
Finally, GAGs are a major component of the extracellu-
lar matrix (ECM), the “filler” substance existing between cells 
in an organism. Here they form larger complexes, binding to 
proteoglycans, to hyaluronan, and to fibrous matrix proteins, 
such as collagen. They have also been shown to bind with 
cations (such as sodium, potassium, and calcium) and with 
water, and their role in regulating the movement of molecules 
through or within the ECM has also been demonstrated. 
Individual functions of proteoglycans can be attributed to 
either the protein core or the attached GAG chain.1,2
For all these reasons, GAGs are considered to be the 
“glue” of the cornea, responsible for providing plasticity and 
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the structural support needed for successful corneal function. 
Along with other molecules, GAGs form the solid portion 
of the cornea (22%), the remainder being water.3 The corneal 
transparency is due to the uniform distribution of collagen 
fibrils, which is regulated by proteoglycans.4
The first studies on the role of GAGs in corneal disorders 
date back to 1969.5
In the years that followed, numerous studies were per-
formed on corneal cells and the role of GAGs was investigated 
in various species, such as chicks6 and rabbits,7,8 and also in 
humans.9,10 At the same time, the biosynthetic mechanisms 
of sulfated GAGs were particularly studied,11 as were their 
metabolism and functions.12 Finally, biochemical measure-
ment in tissue extracts has also been performed.13,14 Sulfated 
GAGs were considered to be pathognomonic factors in some 
corneal diseases, including corneal explant.15–18
In fact, the α-keratan sulfate proteoglycan appears to play 
a key role in the transparency of the cornea, while the major 
keratan sulfate proteoglycan, present in large quantities in the 
corneal stroma, seems to regulate the organization of collagen 
fibrils and is involved in wound repair of epithelial tissues of 
the human cornea.19,20 Proteoglycans, mucous proteins, and 
mucopolysaccharides, as stated, are the historic terms for the 
chemical substances today referred to as GAGs.21,22
Mucopolysaccharides are present in excess in a group of 
diseases named mucopolysaccharidoses.23 Hurler’s mucopoly-
saccharidosis starts with a corneal clouding that worsens with 
other dangerous illness, as reported by Iozzo.16 This author 
demonstrated the involvement of GAGs within the corneal 
structure and in the maintenance of its transparency.
GAGs were particularly studied in relation to age- 
related changes in human plasma24–26 and also regarding their 
role in the trabecular meshwork of the human eye.27,28 The 
aim of this work is to evaluate possible age-related changes in 
the human cornea, particularly in relation to the role played 
by GAGs.
materials and methods
Samples of human cornea taken from 12 younger (age 21 ± 
1.2 years) and 12 older (age 72 ± 1.6 years) male subjects 
were harvested from autopsies, without any aesthetic damage 
to the corpses. As post-mortem phenomena may produce 
early morphological modifications of the corneal structures, 
our samples were harvested as early as possible after death 
(12–18 hours).
The Ethics Committees of the Hospitals participating 
in the study gave their approval for the study, and the rela-
tives of the sampled subjects gave their written informed 
consent for the harvesting and use of the samples. Experi-
ments were in accordance with the ethical standards of 
the responsible committee and with the Declaration of 
Helsinki.
Samples of the human cornea (3 mg weight) were 
homogenized using a modified Potter-Elvehjem homogenizer 
(glass/glass), in an ice-cold buffer solution 1/10 w/v of veronal-
acetate (pH 7.4).
Each homogenate was centrifuged in a 0.656 M sucrose 
gradient solution containing 1 mM-ethylenediaminetetraacetic 
acid (EDTA). The tubes were centrifuged for 30 minutes 
at 47.000g (21.500 rpm) in the Spinco SW 25.1 rotor. Six 
fractions were obtained: (1) supernatant A, (2) membranes, 
(3) supernatant B, (4) mitochondria, (5) cytosol, and (6) pel-
let. Layers 1, 3, and 5 constituted the liquid phases, while lay-
ers 2, 4, and 6 comprised the solid phases. The liquid phases 
were collected and used for the separation of GAGs.29
Tissue protein concentrations in all our samples were 
determined using the method described by Lowry et al,30 
using bovine serum albumin (BSA) as standard, and Folin 
phenol was used as the reagent.
elution and concentration of total GAGs. GAGs were 
isolated from the supernatants using ion-exchange chro-
matography on Diethylaminoethyl–Sephacel, according to 
De Muro.31 The fraction containing GAGs was collected, 
lyophilized, and stored at −20 °C until used for biochemical 
analysis.
Preparation of GAG subfractions. Samples of total 
GAGs were subjected to enzymatic digestion, capable of 
specifically eliminating particular GAG types. The follow-
ing GAG digestion factors were used: chondroitinase ABC 
and/or nitrous acid.
digestion with chondroitinase A. Cleavage with chon-
droitinase A, which specifically degraded chondroitin-sulfate, 
allowed dermatan sulfate and heparan sulfate, or hyaluronic 
acid, to be retained. The digestion process was performed 
using only chondroitinase A (0.05 M) in Tris-HCl buffer 
(50 nM, pH 7.3).
digestion with nitrous acid. Nitrous acid was used in 
order to remove HS/H. Samples of serum GAGs subjected 
earlier to enzymatic depolymerization with chondroitinase 
ABC or AC, respectively, were additionally treated with 
nitrous acid, according to Lagunoff and Warren.32
All the subfractions containing the different types of 
GAGs were collected, lyophilized, and stored at -20 °C until 
used for biochemical analysis.
Assay of GAGs and/or their subfractions. The amount 
of total GAGs and/or their subfractions was quantified by 
hexuronic acid biochemical assay, according to Blumenkrantz 
and Asboe-Hansen,33 taking into account modifications pro-
posed by Slim et al.34 The concentrations were expressed as 
milligrams of hexuronic acid per gram of protein.
statistics. Mean values, maximum and minimum lim-
its (experimental values), variations, standard deviation (SD), 
standard error of the mean (SEM), and correlation coefficients 
were calculated.
A correlative analysis of molecular and biochemical 
data was performed by comparing the significant dif-
ferences in each group with the corresponding values in 
other homogenous groups. The significance of differences 
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between age groups was assessed using Duncan’s multiple 
range test.35
results
The clinically relevant data of the subjects from whom the 
corneas were harvested are shown in Table 1. The corneas of 
the 12 eyes of young people, and those of 12 elders, did not 
have any macroscopic or microscopic abnormalities. More-
over, no donor was suffering from other general diseases that 
might have impacted on the local diseases of the eye and/or 
of the cornea.
Table 2 contains the biochemical values related to the 
quantity of GAGs in the corneal homogenates of the two 
age groups of subjects. As can be seen, the total GAGs count 
was 97.4 ± 6.2 mg of hexuronic acid per gram of protein. In 
the younger subjects, the GAG count was 127.3 ± 8.5 mg of 
hexuronic acid per gram of protein, while in the older sub-
jects, there was a significant increase of about 30% compared 
to younger corneas (Fig. 1).
These changes in total GAG content were associated with 
significant modification of both the quantity and proportion 
of each component of GAG. In contrast, lighter GAGs, such 
as hyaluronic acid, strongly decreased in the older subjects 
(16.2 ± 1.5 mg hexuronic acid per milligram of protein) versus 
young donors (31.9 ± 1.3 mg of uronic acid per milligram of 
protein).
By contrast, the sulfated heavy GAGs, such as chondroi-
tin, dermatan, keratan, and heparan sulfate, strongly increased 
in the older subjects, by about 30–40% with the exception of 
the heparan sulfate, which increased by about 80%. All the 
data present in Table 2 were statistically significant (P , 0.05) 
(Figs. 2 and 3).
discussion
The human cornea presented age-related changes, as evidenced 
by our biochemical and molecular results. The total GAGs and 
sulfated heavy GAGs, such as chondroitin, dermatan, keratan 
and heparan sulfate, were higher in the older subjects than in 
the younger subjects; at the same time, the hyaluronic acid 
count was significantly higher in the younger subjects than 
in the older subjects. Hyaluronic acid count was significantly 
higher in the younger subjects than in the older subjects. The 
sulfated heavy GAGs, such as chondroitin, dermatan, keratan, 
and heparan sulfate, were lower in the younger subjects than 
in the older subjects.
The corneas of the elderly are more susceptible to oxidative 
injury in comparison to the corneas of younger people.36–38 More-
over, the activities of all antioxidant enzymes were dramatically 
decreased in aged eyes. The decrease in enzymes that normally 
metabolize and detoxify hydrogen peroxide and other free radicals 
can account for the alteration in levels of GAGs in the elderly.38
The cornea is a peculiar and multifunctional structure of the 
eyeball, as its transparency permits light perception by the retina; 
its shape contributes to the refractive power responsible for appro-
priate sight; and together with the sclera, it forms a protective 
envelop for delicate vascular and neuronal intraocular structures. 
All these functions depend mainly on the integrity of the corneal 
stroma, a unique transparent connective tissue layer, which repre-
sents approximately nine-tenth of the corneal thickness.39
From the late ‘80s, but particularly in the last ten years, sig-
nificantly increased clinical interests on corneal microsurgery 
as the refractive surgery, ie, surgical interventions on the 
table 1. Clinical data of donor subject from which small fragments of 
cornea were harvested.
numbeR of  
pAtientS
AGe RAnGe Sex eYe And CoRneA
12 20 ± 1.2* male no ocular and/or  
cornea diseases
12 72 ± 1.6* male no ocular and/or  
cornea diseases
note: *Results are reported in years ± sd.
table 2. Quantitative analysis of gags in the corneal tissues of 
young and old subjects.
findinGS YounG (n = 12) old (n = 12) P*
total gags 97.4 ± 6.2 127.3 ± 8.5 ,0.05
hyaluronic acid 31.9 ± 1.3 16.2 ± 1.5 ,0.05
Chondroitin sulphate 12.5 ± 1.4 18.8 ± 1.6 ,0.05
dermatan sulphate 21.5 ± 1.8 28.6 ± 1.8 ,0.05
Keratan sulphate 18.3 ± 1.6 31.5 ± 1.4 ,0.05
heparan sulphate 15.4 ± 1.2 26.8 ± 1.2 ,0.05
notes: all results are expressed as µm of hexuronic acids / g proteins. *P was 
assessed comparing the values of young versus of corneas and considered 
significant if P , 0.05. duncan’s multiple range test was calculated comparing 
young and old corneas.
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figure 1. Comparison of total gag content of young and old human 
corneas: Total GAG content was significantly higher in old corneas as 
compared to young corneas (,0,05).
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figure 2. Comparison of the gag content of young and old human corneas: the proportion of hyaluronic acid (ha) was higher in the young corneas, while 
the proportion of sulfated gags (Chs, ds, Ks, hs) was lower in young corneas as compared to old corneas.
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figure 3. Comparison of GAG composition of young and old human corneas: hyaluronic acid (HA) content is significantly higher in young corneas 
(,0,05), while chondroitin-sulfate (ChS), dermatan sulfate (DS), heratan sulfat (KS) and heparan sulfate (HS) content is significantly lower (,0,05) as 
compared to old corneas. 
curvature of the cornea in myopia, in hypermetropy and astig-
matism, and even more in presbyopia, have become more and 
more common worldwide and have opened new perspectives 
to improve visual performance at any age. Furthermore, new 
microsurgery techniques have been developed for corneal 
transplantation of any part of the cornea. These interventions 
cause damage to the corneal stroma and particularly to the 
innervation of the cornea. Even if this damage is progressively 
less extensive by using laser technology, the wound healing of 
the stroma highly depends on the GAG as their composition 
profoundly modify the all post-operative functions of the cor-
nea for both short and long terms.40–42
Taking together our findings on age-related changes in 
the cornea and the rapidly growing prevalence of corneal sur-
gery we may conclude: any intervention on the cornea should 
be customized considering also the age of subject; specifi-
cally, how the age will influence the outcome of surgery, and 
any intervention on the cornea should consider future aging; 
GAGs in human cornea
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specifically, how the intervention will influence the physi-
ological aging of the cornea. Further studies are certainly 
needed to reach deeper knowledge on the corneal structure 
and pathophysiology to planning customized interventions, 
in particular, regarding aging and age-related changes.
Our results provide direct evidence that GAGs play an 
important role in age-related diseases of the human cornea; 
however, there is no direct experiment to show this in the cur-
rent manuscript. Their quantity is significantly affected in the 
elderly in comparison with younger subjects.
A distinction must be made between conditions consid-
ered within the boundaries of normal aging and those of true 
disease processes affecting the cornea in the elderly.
conclusions
GAGs perform numerous vital functions within the human 
cornea. They provide corneal hydration, structural integrity, 
transparency and thickness. Aging results in an altered com-
position of GAGs in the cornea. For this reason, the corneas 
of the elderly are more susceptible to oxidative damage.
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